1. Home
  2. SEV vs CPIX Comparison

SEV vs CPIX Comparison

Compare SEV & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aptera Motors Corp.

SEV

Aptera Motors Corp.

HOLD

Current Price

$1.89

Market Cap

83.9M

Sector

Industrials

ML Signal

HOLD

Logo Cumberland Pharmaceuticals Inc.

CPIX

Cumberland Pharmaceuticals Inc.

HOLD

Current Price

$7.82

Market Cap

92.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SEV
CPIX
Founded
2019
1999
Country
United States
United States
Employees
46
N/A
Industry
Auto Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
83.9M
92.3M
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
SEV
CPIX
Price
$1.89
$7.82
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
271.8K
64.0K
Earning Date
05-16-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
58.70
EPS
N/A
N/A
Revenue
N/A
$42,010,949.00
Revenue This Year
N/A
N/A
Revenue Next Year
$17,757.14
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
16.75
52 Week Low
$1.29
$1.85
52 Week High
$11.24
$7.36

Technical Indicators

Market Signals
Indicator
SEV
CPIX
Relative Strength Index (RSI) 36.41 69.82
Support Level $1.29 $5.42
Resistance Level $2.45 N/A
Average True Range (ATR) 0.15 0.62
MACD -0.03 0.07
Stochastic Oscillator 17.57 94.63

Price Performance

Historical Comparison
SEV
CPIX

About SEV Aptera Motors Corp.

Aptera Motors Corp engages in the development, production, and distribution of energy efficient solar-powered, battery-electric vehicles. The company has designed the Aptera vehicle to provide up to an estimated 40 miles per day by collecting energy from the sun and storing it in its proprietary battery pack. The company operates as a single reportable segment focused on the development of solar electric vehicles.

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.

Share on Social Networks: